Eptifibatide provides additional platelet inhibition in Non–ST-Elevation myocardial infarction patients already treated with aspirin and clopidogrel-Reference-Cited by-同舟云学术

Eptifibatide provides additional platelet inhibition in Non–ST-Elevation myocardial infarction patients already treated with aspirin and clopidogrel

Published:2004-01 Issue:2 Volume:43 Page:162-168
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Dalby Miles,Montalescot Gilles,Sollier Claire Bal dit,Vicaut Eric,Soulat Thierry,Collet Jean-Philippe,Choussat Rémi,Gallois Vanessa,Drobinski Gérard,Drouet Ludovic,Thomas Daniel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

2. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non–Q-wave myocardial infarction;N Engl J Med,1998

3. Inhibition of platelet glyco-protein IIb/IIIa with eptifibatide in patients with acute coronary syndromes;N Engl J Med,1998

4. Effect of Ca2+on GP IIb-IIIa interactions with integrilin;Phillips;Circulation,1997

5. Differential antiplatelet efficacy for various GPIIb/IIIa antagonists;Mousa;Cardiovasc Res,2000

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles;Cardiovascular Drugs and Therapy;2017-11-22

2. Clinical and economic studies of eptifibatide in coronary stenting;Therapeutics and Clinical Risk Management;2014-08

3. Impact of Red Blood Cell Transfusion on Platelet Aggregation and Inflammatory Response in Anemic Coronary and Noncoronary Patients;Journal of the American College of Cardiology;2014-04

4. Microfluidic Thrombosis under Multiple Shear Rates and Antiplatelet Therapy Doses;PLoS ONE;2014-01-03

5. Efficacy and Safety of Abciximab in Diabetic Patients Who Underwent Percutaneous Coronary Intervention with Thienopyridines Loading: A Meta-Analysis;PLoS ONE;2011-06-03